Works matching IS 2160763X AND DT 2022 AND VI 11

Results: 164

Issue Information.

Published in:: Clinical Pharmacology in Drug Development, 2022, v. 11, n. 12, p. 1357, doi. 10.1002/cpdd.834
Publication type:: Article

Authorship.

Published in:

Clinical Pharmacology in Drug Development, 2022, v. 11, n. 12, p. 1362, doi. 10.1002/cpdd.1190

By:

Greenblatt, David J.

Publication type:

Article

Challenges in the Development of Intravenous Neurokinin‐1 Receptor Antagonists: Results of a Safety and Pharmacokinetics Dose‐Finding, Phase 1 Study of Intravenous Fosnetupitant.

Published in:

Clinical Pharmacology in Drug Development, 2022, v. 11, n. 12, p. 1405, doi. 10.1002/cpdd.1183

By:

Tyler, Timothy;
Schultz, Armin;
Venturini, Alessio;
Giuliano, Claudio;
Bernareggi, Alberto;
Spezia, Riccardo;
Voisin, Daniel;
Stella, Valentino

Publication type:

Article

Safety, Pharmacokinetics, and Pharmacodynamics of CC‐90001 (BMS‐986360), a c‐Jun N‐terminal Kinase Inhibitor, in Phase 1 Studies in Healthy Participants.

Published in:

Clinical Pharmacology in Drug Development, 2022, v. 11, n. 12, p. 1394, doi. 10.1002/cpdd.1178

By:

Ye, Ying;
Gaudy, Allison;
Thomas, Michael;
Reyes, Josephine;
Burkhardt, Barbara;
Horan, Gerald;
Liu, Liangang;
Chen, Jian;
Ghosh, Atalanta;
Carayannopoulos, Leonidas N.;
Tatosian, Daniel A.;
Palmisano, Maria

Publication type:

Article

Safety, Tolerability, and Pharmacokinetics of Intravenous Doses of PF‐07304814, a Phosphate Prodrug Protease Inhibitor for the Treatment of SARS‐CoV‐2, in Healthy Adult Participants.

Published in:

Clinical Pharmacology in Drug Development, 2022, v. 11, n. 12, p. 1382, doi. 10.1002/cpdd.1174

By:

Zhu, Tong;
Pawlak, Sylvester;
Toussi, Sima S.;
Hackman, Frances;
Thompson, Kimberly;
Song, Wei;
Salageanu, Joanne;
Winter, Erica;
Shi, Haihong;
Winton, Jennifer;
Binks, Michael

Publication type:

Article

Drug‐Drug Interactions With the Hepatitis B Virus Capsid Assembly Modulator JNJ‐56136379 (Bersacapavir).

Published in:

Clinical Pharmacology in Drug Development, 2022, v. 11, n. 12, p. 1419, doi. 10.1002/cpdd.1164

By:

Vandenbossche, Joris;
Yogaratnam, Jeysen;
Hillewaert, Vera;
Rasschaert, Freya;
Talloen, Willem;
Biewenga, Jeike;
Snoeys, Jan;
Kakuda, Thomas N.;
Palmer, Martyn;
Nangosyah, Julius;
Biermer, Michael

Publication type:

Article

Population Pharmacokinetics of Oral Brepocitinib in Healthy Volunteers and Patients.

Published in:

Clinical Pharmacology in Drug Development, 2022, v. 11, n. 12, p. 1447, doi. 10.1002/cpdd.1163

By:

Hughes, Jim H.;
Qiu, Ruolun;
Banfield, Christopher;
Dowty, Martin E.;
Nicholas, Timothy

Publication type:

Article

Population Pharmacokinetics of Oral Migalastat in Adolescents and Adults With and Without Renal Impairment.

Published in:

Clinical Pharmacology in Drug Development, 2022, v. 11, n. 12, p. 1367, doi. 10.1002/cpdd.1160

By:

Leonowens, Cathrine;
Schmith, Virginia;
Zhou, Jie;
Wu, Yi Shuan;
Ivaturi, Vijay;
Johnson, Franklin K.

Publication type:

Article

Pharmacokinetic and Bioequivalence Study of Eldecalcitol Soft Capsules in Healthy Chinese Subjects.

Published in:

Clinical Pharmacology in Drug Development, 2022, v. 11, n. 12, p. 1474, doi. 10.1002/cpdd.1159

By:

Li, Ting;
Sun, Feifei;
Liu, Yanping;
Su, Lingping;
Shi, Ping;
Li, Xin;
Liu, Shuqin;
Wang, Chenjing;
Shen, Linjing;
Cao, Yu;
Wang, Shumin

Publication type:

Article

Bioequivalence of China‐ and Germany‐Manufactured Metformin Extended‐Release Tablets Under Fed and Fasted Conditions in Healthy Volunteers: A Randomized, Open‐Label, 2‐Way Crossover Study.

Published in:

Clinical Pharmacology in Drug Development, 2022, v. 11, n. 12, p. 1430, doi. 10.1002/cpdd.1158

By:

Hu, Chaoying;
Pei, Tong;
Li, Dandan;
Zhou, Dongli;
Zhang, Lan

Publication type:

Article

Bioequivalence and Pharmacokinetic Study of 2 Edoxaban Tablets in Healthy Chinese Subjects.

Published in:

Clinical Pharmacology in Drug Development, 2022, v. 11, n. 12, p. 1440, doi. 10.1002/cpdd.1156

By:

Liu, Lihua;
Li, Xin;
Liu, Yujie;
Xu, Bing;
Li, Yuan;
Yuan, Fang;
Zhang, Ping;
Tu, Shengqing;
Hu, Wenhui

Publication type:

Article

Bioequivalence of Two Linezolid Tablets Under Fed and Fasting Conditions in Healthy Chinese Individuals.

Published in:

Clinical Pharmacology in Drug Development, 2022, v. 11, n. 12, p. 1481, doi. 10.1002/cpdd.1155

By:

Wang, Shumin;
Guo, Shaojie;
Han, Ying;
Ni, Siyang;
Wu, Feng;
Dai, Yuyang;
Xia, Qiang;
Yang, Yan;
Zhao, Xiuli

Publication type:

Article

PKPD Modeling and Simulations to Support Biosimilar Development of Biphasic Insulin Aspart 30.

Published in:

Clinical Pharmacology in Drug Development, 2022, v. 11, n. 12, p. 1457, doi. 10.1002/cpdd.1152

By:

Petrov, Aleksandr V.;
Zinnatulina, Bella R.;
Drai, Roman V.;
Karonova, Tatiana L.;
Koksharova, Ekaterina O.;
Dorotenko, Artem R.;
Makarenko, Igor E.

Publication type:

Article

Pharmacokinetics and Safety Study of HN0037, a Novel Anti‐Human Herpes Simplex Virus Inhibitor, in Healthy Volunteers.

Published in:

Clinical Pharmacology in Drug Development, 2022, v. 11, n. 12, p. 1467, doi. 10.1002/cpdd.1138

By:

Hou, Jie;
Gao, Hong;
Fan, Yingzhe;
Wang, Ying;
Qin, Meng;
Di, Yujing;
Wang, Lu;
Zhou, Xin;
Zhou, Yi;
Qin, Donghui;
Hill, George

Publication type:

Article

Issue Information.

Published in:: Clinical Pharmacology in Drug Development, 2022, v. 11, n. 11, p. 1241, doi. 10.1002/cpdd.833
Publication type:: Article

Bioequivalence of Pomalidomide Capsules in Fasting and Fed States in Healthy Male Volunteers: A Randomized, Open, Single‐Dose, Biperiodic, Double‐Crossover Study.

Published in:

Clinical Pharmacology in Drug Development, 2022, v. 11, n. 11, p. 1246, doi. 10.1002/cpdd.1173

By:

Wang, Yannan;
Lin, Sisi;
Wang, Ying;
Wang, Zhuoyan

Publication type:

Article

Pharmacokinetics and Safety of Vibegron 75 mg Administered as an Intact or Crushed Tablet in Healthy Adults.

Published in:

Clinical Pharmacology in Drug Development, 2022, v. 11, n. 11, p. 1349, doi. 10.1002/cpdd.1169

By:

King, Jennifer;
Walker, Ann;
Aikin, Dorothy;
Haag‐Molkenteller, Cornelia;
Kankam, Martin

Publication type:

Article

Randomized Trial of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GSK2831781 in Healthy Japanese and White Participants.

Published in:

Clinical Pharmacology in Drug Development, 2022, v. 11, n. 11, p. 1284, doi. 10.1002/cpdd.1165

By:

Liefaard, Lia;
Hajduk, Eva;
van den Berg, Frans;
Panoilia, Eirini;
Bouma, Gerben;
Lisi, Edoardo;
Srinivasan, Naren;
Cui, Yi;
Gross, Annette S.;
Tarzi, Ruth;
Marks, Daniel J.B.

Publication type:

Article

Bioequivalence and Relative Bioavailability Studies to Assess a New Acalabrutinib Formulation That Enables Coadministration With Proton‐Pump Inhibitors.

Published in:

Clinical Pharmacology in Drug Development, 2022, v. 11, n. 11, p. 1294, doi. 10.1002/cpdd.1153

By:

Sharma, Shringi;
Pepin, Xavier;
Burri, Harini;
Zheng, Lianqing;
Kuptsova‐Clarkson, Nataliya;
de Jong, Anouk;
Yu, Ting;
MacArthur, Holly L.;
Majewski, Michal;
Byrd, John C.;
Furman, Richard R.;
Ware, Joseph A.;
Mann, James;
Ramies, David;
Munugalavadla, Veerendra;
Sheridan, Louise;
Tomkinson, Helen

Publication type:

Article

An Open‐Label Study to Evaluate the Effect of Eluxadoline on the Single‐Dose Pharmacokinetics of Midazolam in Healthy Participants.

Published in:

Clinical Pharmacology in Drug Development, 2022, v. 11, n. 11, p. 1341, doi. 10.1002/cpdd.1150

By:

Boinpally, Ramesh;
McGeeney, Danielle;
Kaczynski, Edward;
Weissman, Darren

Publication type:

Article

An Open‐Label, Randomized Pharmacokinetic Study of 2 Formulations of Eldecalcitol Capsules Following Single Oral Administration in Healthy Chinese Volunteers Under Fasting and Fed Conditions.

Published in:

Clinical Pharmacology in Drug Development, 2022, v. 11, n. 11, p. 1322, doi. 10.1002/cpdd.1144

By:

Wu, Juan;
Fan, Yuru;
Zheng, Liang;
Wang, Zhiqiang;
Liu, Yueyue;
Shen, Chenlin;
Hu, Wei

Publication type:

Article

Population Pharmacokinetics of Heptanoate in Healthy Subjects and Patients With Long‐Chain Fatty Acid Oxidation Disorders Treated With Triheptanoin.

Published in:

Clinical Pharmacology in Drug Development, 2022, v. 11, n. 11, p. 1264, doi. 10.1002/cpdd.1145

By:

Lee, Sun Ku;
Gosselin, Nathalie H.;
Jomphe, Claudia;
McKeever, Kathleen;
Putnam, Wendy

Publication type:

Article

Pharmacokinetics of Amoxicillin and Clavulanate Potassium for Suspension (200 mg/28.5 mg) in Healthy Subjects: Sample Add Stabilizer Study and Food Effects.

Published in:

Clinical Pharmacology in Drug Development, 2022, v. 11, n. 11, p. 1314, doi. 10.1002/cpdd.1143

By:

Xu, Su‐Mei;
Qin, Fei;
Zhang, Yong‐Dong;
Xu, Ping‐Sheng

Publication type:

Article

Effect of Meal Timings and Meal Content on the AUC<sub>0‐12h</sub> of Mycophenolic Acid: A Simulation Study.

Published in:

Clinical Pharmacology in Drug Development, 2022, v. 11, n. 11, p. 1331, doi. 10.1002/cpdd.1141

By:

Qian, Lixuan;
Jiao, Zheng;
Zhong, Mingkang

Publication type:

Article

Drug‐Drug Interaction Studies to Evaluate the Effect of Inhibition of UGT1A1 and CYP3A4 and Induction of CYP3A4 on the Pharmacokinetics of Tropifexor in Healthy Subjects.

Published in:

Clinical Pharmacology in Drug Development, 2022, v. 11, n. 11, p. 1253, doi. 10.1002/cpdd.1140

By:

Chen, Jin;
Stringer, Rowan;
Shah, Bharti;
Gu, Jessie;
Zhang, Yiming;
Hackling, Melissa;
Prince, William;
Woessner, Ralph

Publication type:

Article

Pharmacokinetics of Esomeprazole Magnesium After Single Oral Doses in Healthy Subjects: Bioequivalence Study and Food Effects.

Published in:

Clinical Pharmacology in Drug Development, 2022, v. 11, n. 11, p. 1308, doi. 10.1002/cpdd.1139

By:

Zhong, Xue‐Feng;
Zhou, Gan;
Xu, Su‐Mei;
Li, Xiao‐Min;
Xu, Ying;
Liu, Wan‐Li;
Zhang, Yan‐Xin;
He, Lin‐Cong;
Shen, Qiu‐Ying;
Xu, Ping‐Sheng

Publication type:

Article

Pharmacokinetic Characteristics, Safety, and Tolerability of Telitacicept, an Injectable Recombinant Human B‐Lymphocyte Stimulating Factor Receptor‐Antibody Fusion Protein, in Healthy Chinese Subjects.

Published in:

Clinical Pharmacology in Drug Development, 2022, v. 11, n. 11, p. 1273, doi. 10.1002/cpdd.1136

By:

Xie, Jing;
Fan, Xiaoyun;
Su, Yue;
Zhou, Huan;
Cao, Shugang;
Zhu, Xingyu;
Zhu, Minhui;
He, Cuixia;
Wang, Ying;
Fan, Ling;
Ge, Qin;
Zhu, Juan;
Liu, Bingyan;
Chen, Xiao;
Xie, Yunqiu;
Ma, Ling;
Liu, Yuanyuan;
Chen, Juan;
Wang, Huaxue;
Li, Zhijun

Publication type:

Article

Issue Information.

Published in:: Clinical Pharmacology in Drug Development, 2022, v. 11, n. 10, p. 1125, doi. 10.1002/cpdd.832
Publication type:: Article

A Consideration of Fixed Dosing Versus Body Size‐Based Dosing Strategies for Chimeric Antigen Receptor T‐Cell Therapies.

Published in:

Clinical Pharmacology in Drug Development, 2022, v. 11, n. 10, p. 1130, doi. 10.1002/cpdd.1171

By:

He, Jimmy Zhijian;
Wang, Hechuan;
Lim, KyoungSoo;
Ren, Song;
Rollins, Fred;
Vallaster, Markus;
Wong, Ryan;
Stebbings, Richard;
Standifer, Nathan;
Keefe, Robert;
Phipps, Alex;
Gibbs, Megan

Publication type:

Article

Preclinical and Phase 1 Assessment of Antisense Oligonucleotide Bepirovirsen in Hepatitis B Virus–Transgenic Mice and Healthy Human Volunteers: Support for Clinical Dose Selection and Evaluation of Safety, Tolerability, and Pharmacokinetics of Single and Multiple Doses

Published in:

Clinical Pharmacology in Drug Development, 2022, v. 11, n. 10, p. 1191, doi. 10.1002/cpdd.1154

By:

Han, Kelong;
Theodore, Dickens;
McMullen, Gina;
Swayze, Eric;
McCaleb, Michael;
Billioud, Gaetan;
Wieland, Stefan;
Hood, Steve;
Paff, Melanie;
Bennett, C. Frank;
Kwoh, T. Jesse

Publication type:

Article

Pharmacokinetics, Bioequivalence, and Safety Studies of a Generic Selective Tyrosine Kinase Inhibitor Nilotinib Capsule Versus a Branded Product in Healthy Chinese Volunteers.

Published in:

Clinical Pharmacology in Drug Development, 2022, v. 11, n. 10, p. 1233, doi. 10.1002/cpdd.1148

By:

Wang, Meng;
Zhu, Yifang;
Huang, Ming;
Wang, Hao;
Zhou, Wenjia;
Lu, Dan;
Zhang, Quanying

Publication type:

Article

Phase 1 Study to Investigate the Safety, Tolerability, and Pharmacokinetics of EPI‐589 in Healthy Participants.

Published in:

Clinical Pharmacology in Drug Development, 2022, v. 11, n. 10, p. 1136, doi. 10.1002/cpdd.1146

By:

Noda, Naoto;
Hamatani, Tatsuto;
Shibue, Yuta;
Takagaki, Takeshi;
Kitamura, Atsushi;
Haranaka, Miwa;
Ogama, Yoichiro;
Kakuyama, Hiroyoshi

Publication type:

Article

A Phase 1 Thorough QT/QTc Study of Therapeutic and Supratherapeutic Doses of Belumosudil in Healthy Subjects.

Published in:

Clinical Pharmacology in Drug Development, 2022, v. 11, n. 10, p. 1221, doi. 10.1002/cpdd.1142

By:

Schueller, Olivier;
Lohmer, Lauren;
Xue, Hongqi;
Darpo, Borje;
Patel, Jeegar

Publication type:

Article

Pharmacokinetic and Safety Comparison of 2 Afatinib Dimaleate Tablets in Healthy Chinese Volunteers Under Fasted Conditions: A Randomized, Open‐Label, 2‐Period, Single‐Dose Crossover Study.

Published in:

Clinical Pharmacology in Drug Development, 2022, v. 11, n. 10, p. 1177, doi. 10.1002/cpdd.1134

By:

Shi, Ping;
Jiang, Xin;
Tao, Ye;
Li, Ting;
Li, Xin;
Wang, Chenjing;
Liu, Yanping;
Ma, Yaping;
Gao, Xiaomeng;
Cao, Yu

Publication type:

Article

A Reference‐Scaled Average Bioequivalence Study of Azithromycin Tablets Manufactured in China and the United States: An Open‐Label, Randomized, Single‐Dose, 3‐Way Crossover Study in Healthy Chinese Subjects Under Fasted and Fed Conditions

Published in:

Clinical Pharmacology in Drug Development, 2022, v. 11, n. 10, p. 1147, doi. 10.1002/cpdd.1132

By:

Ge, Beikang;
Li, Cuiyun;
Wei, Hua;
Ding, Yanhua;
Wu, Min;
Liu, Yuwang;
Zhang, Kaiting;
Peng, Ao

Publication type:

Article

Comparative Bioavailability of a Single Dose of Trametinib (TMT212) Containing 9% vs 11% Dimethyl Sulfoxide in Randomized Healthy Volunteers to Assess Long‐Term Storage at Room Temperature.

Published in:

Clinical Pharmacology in Drug Development, 2022, v. 11, n. 10, p. 1203, doi. 10.1002/cpdd.1129

By:

Tan, Eugene Y.;
Chiparus, Ovidiu;
Choudhury, Somesh;
Kim, Christina;
Lau, Mike;
Ziltener, Christoph;
Ilankumaran, Palanichamy

Publication type:

Article

Issue Information.

Published in:: Clinical Pharmacology in Drug Development, 2022, v. 11, n. 9, p. 1007, doi. 10.1002/cpdd.831
Publication type:: Article

A Randomized Thorough QT Study of Apomorphine Sublingual Film in Patients With Parkinson's Disease.

Published in:

Clinical Pharmacology in Drug Development, 2022, v. 11, n. 9, p. 1068, doi. 10.1002/cpdd.1147

By:

Stocchi, Fabrizio;
Peckham, Elizabeth L.;
De Pandis, Maria Francesca;
Sciarappa, Ken;
Kleiman, Robert;
Agbo, Felix;
Olanow, C. Warren;
Blum, David;
Navia, Bradford

Publication type:

Article

The Safety, Toleration, and Pharmacokinetics of Two Intravenous Voriconazole Formulations in Healthy Chinese Volunteers After Increasing Dose Administrations.

Published in:

Clinical Pharmacology in Drug Development, 2022, v. 11, n. 10, p. 1211, doi. 10.1002/cpdd.1126

By:

Chen, Gang;
Wang, Zejuan;
Liu, Xiaona;
Zhang, Yanan;
Li, Min;
Du, Aihua;
Zhen, Haiqing;
Wang, Xiaolin;
Zhang, Dan;
Zhang, Mengke;
Zang, Siqi;
Zhang, Lina;
Zhu, Huiting;
Wang, Jin

Publication type:

Article

Effects of CYP3A Inhibition, CYP3A Induction, and Gastric Acid Reduction on the Pharmacokinetics of Ripretinib, a Switch Control KIT Tyrosine Kinase Inhibitor.

Published in:

Clinical Pharmacology in Drug Development, 2022, v. 11, n. 10, p. 1165, doi. 10.1002/cpdd.1110

By:

Li, Xiaoyan;
Shelton, Mark J;
Wang, Jing;
Meade, Julie;
Ruiz‐Soto, Rodrigo

Publication type:

Article

Pharmacokinetics and Bioequivalence of Single‐Oral‐Dose Linagliptin: A Randomized, 2‐Period Crossover Trial in Chinese Healthy Subjects Under Fasting and Fed Conditions.

Published in:

Clinical Pharmacology in Drug Development, 2022, v. 11, n. 10, p. 1157, doi. 10.1002/cpdd.1104

By:

Li, Yan;
Zhang, Xueyuan;
Qi, Lu;
Tong, Yuanxu;
Bai, Haihong;
Liu, Ju;
Liu, Ying;
Chen, Youli;
Wang, Xinghe

Publication type:

Article

ACCP Abstract Booklet.

Published in:: Clinical Pharmacology in Drug Development, 2022, v. 11, p. 1, doi. 10.1002/cpdd.1151
Publication type:: Article

Safety, Tolerability, and Pharmacokinetics of Single and Multiple Ascending Oral Doses of Youkenafil Hydrochloride, a Phosphodiesterase Type 5 Inhibitor, in Healthy Chinese Male Volunteers.

Published in:

Clinical Pharmacology in Drug Development, 2022, v. 11, n. 10, p. 1184, doi. 10.1002/cpdd.1108

By:

Liang, Beibei;
Wang, Jin;
Bai, Nan;
Chi, Yulong;
Wang, Rui;
Cai, Yun

Publication type:

Article

Issue Information.

Published in:: Clinical Pharmacology in Drug Development, 2022, v. 11, p. i, doi. 10.1002/cpdd.835
Publication type:: Article

A Randomized, Double‐Blind, Parallel Controlled, Single‐Dose Phase I Study Comparing the Pharmacokinetics, Safety, and Immunogenicity of the Infliximab Biosimilar CMAB008 and the Reference Product in Healthy Chinese Male Subjects.

Published in:

Clinical Pharmacology in Drug Development, 2022, v. 11, n. 9, p. 1028, doi. 10.1002/cpdd.1135

By:

Zhou, Ruirui;
Chen, Qian;
Hou, Sheng;
Guo, Huaizu;
Li, Jing;
Qian, Weizhu;
Wang, Hao;
Ou, Lun;
Chen, XiaoFei;
Jiang, Fan;
Jia, Jingying

Publication type:

Article

Phase 1 Study Evaluating Pharmacokinetics and Tolerability of Ofatumumab Combined With Bendamustine in Patients With Indolent B‐Cell Non‐Hodgkin's Lymphoma.

Published in:

Clinical Pharmacology in Drug Development, 2022, v. 11, n. 9, p. 1099, doi. 10.1002/cpdd.1133

By:

Forero‐Torres, Andres;
Chandler, Jason Claud;
Iyer, Swaminathan P.;
Kanate, Abraham S.;
Quinlan, Michelle;
Hoever, Petra;
Izquierdo, Miguel;
Davis, Jaclyn;
Madan, Sumit

Publication type:

Article

Population Pharmacokinetic/Pharmacodynamic Modeling of the Effect of Abrocitinib on QT Intervals in Healthy Volunteers.

Published in:

Clinical Pharmacology in Drug Development, 2022, v. 11, n. 9, p. 1036, doi. 10.1002/cpdd.1111

By:

Wang, Xiaoxing;
Gupta, Pankaj;
Malhotra, Bimal K.;
Farooqui, Saleem Ashley;
Le, Vu H.;
Wojciechowski, Jessica;
Mukherjee, Arnab;
Nicholas, Timothy

Publication type:

Article

Clinical Formulation Bridging of Gefapixant, a P2X3‐Receptor Antagonist, for the Treatment of Chronic Cough.

Published in:

Clinical Pharmacology in Drug Development, 2022, v. 11, n. 9, p. 1054, doi. 10.1002/cpdd.1105

By:

Gupta, Pranav;
Hussain, Azher;
Ford, Anthony P.;
Smith, Steven;
Nussbaum, Jesse C.;
Stoch, Aubrey;
Iwamoto, Marian

Publication type:

Article

First‐in‐Human Single‐Ascending‐Dose, Multiple‐Dose, and Food Interaction Studies of NRD.E1, an Innovative Nonopioid Therapy for Painful Diabetic Peripheral Neuropathy.

Published in:

Clinical Pharmacology in Drug Development, 2022, v. 11, n. 9, p. 1012, doi. 10.1002/cpdd.1103

By:

Tiecke, Eva;
Rainisio, Maurizio;
Guentert, Theodor;
Müller, Stephan;
Hochman, Liat;
Kaplan, Eli;
Mangialaio, Sara

Publication type:

Article

A Pharmacokinetic Bioequivalence Study Comparing Different‐Strength and ‐Size Capsules of Isavuconazonium Sulfate in Healthy Japanese Subjects.

Published in:

Clinical Pharmacology in Drug Development, 2022, v. 11, n. 9, p. 1092, doi. 10.1002/cpdd.1101

By:

Shirae, Shinichiro;
Mori, Yoko;
Kozaki, Tomohito;
Ose, Atsushi;
Hasegawa, Setsuo

Publication type:

Article